Agilent Posts Flat Q1 Revenues | GenomeWeb

NEW YORK (GenomeWeb) – Agilent Technologies reported after the close of the market Tuesday that its revenues for the first quarter were flat year over year.

For the three months ended Jan. 31, Agilent recorded $1.03 billion in revenues, beating the average Wall Street estimate of $1.02 billion.

"Agilent delivered a strong start to the year," Agilent President and CEO Mike McMullen said in a statement. "Revenue and earnings per share exceeded our guidance range, reflecting the strength of Agilent's products, services, and relationships with customers in our markets."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.